Bayer continue to stand by the safety of this device, and although they paid out compensation in the United States, they intend to vigorously challenge any further cases around the world in court. 

You can read their press release here:

https://www.bayer.com.au/en/media-statement-essure-information

Ironically, and in the face of no action for the recall of recipients of this device, Medsafe appears to be less certain of the safety of this device. 

Which again begs the question, why was no nationwide recall initiated for the women who received this device?

You can see those concerns expressed in an email rom Medsafe to the TGA in Australia where they explicitly stated that they were requesting “a number of changes, including removal of the text around recall not related to safety concerns” and for references to ongoing safety to be removed. 

I understand this email was retrieved via the freedoms of information act in Australia by the plaintiff in the recent Australian case. It is however now freely available public information. 

Click to access foi-1173-55.pdf

Given the press release by Bayer, I would suggest that we will be waiting a very long time for those words to be removed from any press release from the manufacturer or the company who imported these into New Zealand. 

Should a lack of action by the importer and manufacturer not be grounds for Medsafe to take stronger action to ensure these women were contacted?